Compare Nuwellis Inc (NUWE) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Nuwellis Inc trades at $2.95 (market cap $1.09M), while Regeneron Pharmaceuticals Inc trades at $670 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 64651.4× Nuwellis Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | REGN | |
|---|---|---|
Market Cap | $1.09M | $70.47B |
Sector | Technology | Health |
52-Week High | $527.46 | $812.27 |
52-Week Low | $2.80 | $545.46 |
Enterprise Value | -$722.58K | $64.42B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
